Do we have enough evidence to use chloroquine/hydroxychloroquine as a public health panacea for COVID-19?
Author:
Publisher
Elsevier BV
Subject
General Medicine
Reference12 articles.
1. Driving forces for COVID-19 clinical trials using chloroquine: the need to choose the right research questions and outcomes;Monteiro;Rev Soc Bras Med Trop,2020
2. Effects of chloroquine on viral infections: an old drug against today's diseases?;Savarino;Lancet Infect Dis,2003
3. Chloroquine and hydroxychloroquine binding to melanin: Some possible consequences for pathologies;Schroeder;Toxicol Rep,2014
Cited by 14 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Implementation of platform trials in the COVID-19 pandemic: A rapid review;Contemporary Clinical Trials;2022-01
2. Pandemia de COVID-19 e as atividades de ensino remotas: riscos ergonômicos e sintomas musculoesqueléticos dos docentes do Instituto Federal Catarinense;Fisioterapia e Pesquisa;2022-01
3. COVID-19 pandemic and remote teaching activities: ergonomic risks and musculoskeletal symptoms of professors at Instituto Federal Catarinense;Fisioterapia e Pesquisa;2022-01
4. Ciência Aberta, acesso aberto: revisão de literatura da comunicação científica sobre Covid-19 na plataforma SciELO (2020);Saúde em Debate;2022
5. Open Science, open access: literature review of the scientific communication about Covid-19 on the SciELO platform (2020);Saúde em Debate;2022
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3